DalsnaFinance Account

UnitedHealth Group $UNH

Health Care · Managed Health Care · NYSE/NASDAQ

S&P 500 Dow Jones Russell 1000 Minnesota

Create a scorecard

$421.82

+14.94 (+3.67%)

As of Oct 20, 2026, 12:08 PM EDT

Price history

Loading chart…

Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Jun 5, 2026, the first target we tracked for UNH.

Key facts

52-week range (closes): $259.02 – $436.35 Lowest close Mar 27, 2026, highest Jul 21, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
Fiscal year ends: December Fiscal 2025 ended Dec 31, 2025, from SEC filings
In the S&P 500 since: Jul 1, 1994 · All S&P 500 changes
In the Dow since: Sep 24, 2012, replacing Kraft Foods (KFT) · Kraft split into Mondelez International and Kraft Foods Group. · All Dow changes
Analyst coverage: 16 open price targets from 13 firms: Bank of America, Morgan Stanley, TD Cowen, Baird, Barclays, Bernstein, Cantor Fitzgerald, KeyBanc Capital Markets, Mizuho, Oppenheimer, RBC Capital Markets, Truist Securities, UBS Approved targets tracked here; see the analyst section below

UnitedHealth Group (UNH) is trading up at $421.82 (+3.67%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Analyst price targets on UNH

Current price targets from 13 firms average $483, median $495, ranging from $402 to $529 — the average is 15% above the current $422. Each is tracked to its date and scored the same way a member's call is.

Baird $389 → $427 by Oct 2027 Neutral Oct 14, 2026 via GuruFocus · Baird's track record
TD Cowen $379 → $402 by Oct 2027 Oct 9, 2026 via GuruFocus · TD Cowen's track record
Cantor Fitzgerald $379 → $495 by Sep 2027 Overweight Sep 11, 2026 via Investing.com · Cantor Fitzgerald's track record
Bernstein $436 → $512 by Jul 2027 Outperform Jul 21, 2026 via Investing.com Canada · Bernstein's track record
Mizuho $422 → $493 by Jul 2027 Outperform Jul 20, 2026 via Investing.com · Mizuho's track record
Bank of America $422 → $512 by Jul 2027 Buy Jul 20, 2026 via Investing.com · Bank of America's track record
Barclays $422 → $441 by Jul 2027 Jul 20, 2026 via GuruFocus · Barclays's track record
Oppenheimer $426 → $500 by Jul 2027 Outperform Jul 17, 2026 via GuruFocus · Oppenheimer's track record
Morgan Stanley $426 → $529 by Jul 2027 Overweight Jul 17, 2026 via GuruFocus · Morgan Stanley's track record
KeyBanc Capital Markets $426 → $500 by Jul 2027 Jul 17, 2026 via GuruFocus · KeyBanc Capital Markets's track record
Truist Securities $426 → $500 by Jul 2027 Buy Jul 17, 2026 via GuruFocus · Truist Securities's track record
RBC Capital Markets $426 → $478 by Jul 2027 Outperform Jul 17, 2026 via GuruFocus · RBC Capital Markets's track record

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

UnitedHealth Group revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)

UnitedHealth Group annual financial statements
	FY2016Dec 2016	FY2017Dec 2017	FY2018Dec 2018	FY2019Dec 2019	FY2020Dec 2020	FY2021Dec 2021	FY2022Dec 2022	FY2023Dec 2023	FY2024Dec 2024	FY2025Dec 2025
Income statement
Revenue	$184.8B	$201.2B	$226.2B	$242.2B	$257.1B	$287.6B	$324.2B	$371.6B	$400.3B	$447.6B
Growth (year over year)	+17.7%	+8.8%	+12.5%	+7.0%	+6.2%	+11.8%	+12.7%	+14.6%	+7.7%	+11.8%
Gross profit	$160.4B	$177.0B	$199.2B	$214.0B	$226.4B	$256.6B	$290.5B	$332.9B	$353.6B	$396.9B
Gross margin	86.8%	88.0%	88.1%	88.4%	88.0%	89.2%	89.6%	89.6%	88.3%	88.7%
Operating income	$12.9B	$15.2B	$17.3B	$19.7B	$22.4B	$24.0B	$28.4B	$32.4B	$32.3B	$19.0B
Operating margin	7.0%	7.6%	7.7%	8.1%	8.7%	8.3%	8.8%	8.7%	8.1%	4.2%
Net income	$7.02B	$10.6B	$12.0B	$13.8B	$15.4B	$17.3B	$20.1B	$22.4B	$14.4B	$12.1B
Net margin	3.8%	5.2%	5.3%	5.7%	6.0%	6.0%	6.2%	6.0%	3.6%	2.7%
EPS (diluted)	$7.25	$10.72	$12.19	$14.33	$16.03	$18.08	$21.18	$23.86	$15.51	$13.23
Balance sheet
Cash and equivalents	$10.4B	$12.0B	$10.9B	$11.0B	$16.9B	$21.4B	$23.4B	$25.4B	$25.3B	$24.4B
Total assets	$122.8B	$139.1B	$152.2B	$173.9B	$197.3B	$212.2B	$245.7B	$273.7B	$298.3B	$309.6B
Total liabilities	$82.6B	$87.0B	$96.0B	$111.7B	$126.8B	$135.7B	$159.4B	$174.8B	$195.7B	$207.9B
Long-term debt	$25.8B	$28.8B	$34.6B	$36.8B	$38.6B	$42.4B	$54.5B	$58.3B	$72.4B	$72.3B
Shareholders' equity	$38.2B	$49.8B	$54.3B	$60.4B	$68.3B	$75.0B	$81.5B	$94.4B	$98.3B	$100.1B
Cash flow
Operating cash flow	$9.79B	$13.6B	$15.7B	$18.5B	$22.2B	$22.3B	$26.2B	$29.1B	$24.2B	$19.7B
Capital expenditure	$1.71B	$2.02B	$2.06B	$2.07B	$2.05B	$2.45B	$2.80B	$3.39B	$3.50B	$3.62B
Free cash flow	$8.09B	$11.6B	$13.7B	$16.4B	$20.1B	$19.9B	$23.4B	$25.7B	$20.7B	$16.1B
Dividends paid	$2.26B	$2.77B	$3.32B	$3.93B	$4.58B	$5.28B	$5.99B	$6.76B	$7.53B	$7.92B
Share buybacks	$1.28B	$1.50B	$4.50B	$5.50B	$4.25B	$5.00B	$7.00B	$8.00B	$9.00B	$5.54B

RevenueNet incomeNet margin (right axis, %)

UnitedHealth Group quarterly financial statements
	Q3 FY24Sep 2024	Q4 FY24^†Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25^†Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Income statement
Revenue	$100.8B	$100.8B	$109.6B	$111.6B	$113.2B	$113.2B	$111.7B	$112.0B
Growth (year over year)	+9.2%	+6.8%	+9.8%	+12.9%	+12.2%	+12.3%	+2.0%	+0.4%
Gross profit	$89.0B	$88.3B	$97.2B	$98.6B	$100.6B	$100.5B	$98.9B	$98.7B
Gross margin	88.3%	87.6%	88.7%	88.3%	88.9%	88.8%	88.5%	88.1%
Operating income	$8.71B	$7.77B	$9.12B	$5.15B	$4.32B	$380.0M	$8.99B	$7.99B
Operating margin	8.6%	7.7%	8.3%	4.6%	3.8%	0.3%	8.0%	7.1%
Net income	$6.05B	$5.54B	$6.29B	$3.41B	$2.35B	$10.0M	$6.28B	$5.48B
Net margin	6.0%	5.5%	5.7%	3.1%	2.1%	0.0%	5.6%	4.9%
EPS (diluted)	$6.51	$5.99	$6.85	$3.74	$2.59	$0.05	$6.90	$6.04
Balance sheet
Cash and equivalents	$32.4B	$25.3B	$30.7B	$28.6B	$27.2B	$24.4B	$28.0B	$28.6B
Total assets	$299.3B	$298.3B	$309.8B	$308.6B	$315.3B	$309.6B	$312.6B	$309.7B
Total liabilities	$194.9B	$195.7B	$204.6B	$203.8B	$209.5B	$207.9B	$207.3B	$203.8B
Long-term debt	$74.1B	$72.4B	$71.3B	$73.5B	$72.4B	$72.3B	$71.4B	$69.5B
Shareholders' equity	$99.9B	$98.3B	$100.8B	$100.5B	$101.6B	$100.1B	$103.9B	$104.5B
Cash flow
Operating cash flow	$13.9B	$2.37B	$5.46B	$7.19B	$5.95B	$1.11B	$8.91B	$11.1B
Capital expenditure	$991.0M	$912.0M	$898.0M	$886.0M	$890.0M	$948.0M	$763.0M	$799.0M
Free cash flow	$13.0B	$1.46B	$4.56B	$6.30B	$5.05B	$160.0M	$8.15B	$10.3B
Dividends paid	$1.94B	$1.93B	$1.91B	$2.00B	$2.00B	$2.00B	$2.00B	$2.09B
Share buybacks	$956.0M	$4.97B	$3.00B	$2.54B	$0	$0	$0	$1.65B

From UnitedHealth Group's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

UnitedHealth Group vs the Health Care sector and the S&P 500

UnitedHealth Group's latest reported figures next to the median of the other 59 S&P 500 Health Care companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.

UnitedHealth Group compared with the median Health Care company and the median S&P 500 company
Measure	UnitedHealth Group	Health Care (59 other S&P 500 companies)	S&P 500 (502 other companies)
Revenue growth, latest fiscal year	+11.8%	+7.1%	+7.0%
Net margin, latest fiscal year	2.7%	13.1%	13.0%
Dividend per share, latest fiscal year	$8.73	$2.43	$2.40
Share price change, 1 year	+11.6%	+19.8%	+5.6%

UnitedHealth Group: fiscal year ended December 2025, from its 10-K and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, UnitedHealth Group included, are the last regular-session prices of October 19, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 59/496, net margin 59/496, dividend per share 32/349, 1-year price change 59/490; the reasons below can overlap. 12 are left out of the price figure because our archive holds no comparable close for them; dividend medians are among the 32 sector and 349 S&P 500 companies reporting a per-share dividend. The S&P 500 price figure is the middle company's change, not the index's return.

About UnitedHealth Group

UnitedHealth Group Incorporated is an American multinational company based in Eden Prairie, Minnesota, specializing in health insurance and health care services. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's nineth-largest company by revenue and the largest health care company by revenue. The company is ranked fourth on the 2026 Fortune Global 500.

Source: Wikipedia — UnitedHealth Group